News Briefs | March 2022
Robertson named prevention and screening program lead
Mary Robertson has been named the prevention and screening program lead with the cancer center’s Office of Community Outreach and Engagement.
In this role, she is responsible for strategic planning and implementation of working with community partners to implement evidence-based cancer prevention and screening programs throughout Indiana. She will develop programs aimed at reaching racial, ethnic, and socioeconomic groups most in need with accurate cancer information.
Robertson was most recently the executive director of the Indiana Cancer Consortium.
She holds a bachelor’s and a master’s in public health, health policy and management concentration from Purdue and IUPUI, respectively.
Robertson can be reached at rober243@iu.edu or 278-0357. Her office is in the Clinical Building (CL), room 601.
Upcoming events
Thomas Imperiale, MD, to present at the 2022 Distinguished Professors Symposium
Recently named an IU Distinguished Professor, Thomas Imperiale, MD, will present during the 2022 Distinguished Professors Symposium. He is one of five presenters scheduled to speak at 3 p.m. Tuesday, April 19. Short presentations will be shared on outstanding scholarship, artistic or literary distinction, or other achievements that have won significant recognition by peers. Read about Imperiale’s achievements on the honoree profile page. To attend the event in Bloomington, register online.
Global Oncology Seminar Series to highlight AMPATH
Patrick J. Loehrer Sr., MD, will present “Global Oncology – The AMPATH Experiment” at 8 a.m. Thursday, April 7. The Global Oncology Seminar Series is hosted by the Center for Global Oncology and Health Equity at the IU Simon Comprehensive Cancer Center. Join the virtual event.
Cancer center members in the news
Cary- Clint Cary, MD, MPH (CPC), was named a 2022 Young Urologist of the Year by the American Urological Association.
- Attaya Suvannasankha, MD (HHM), will speak at the Myeloma Crowd Round Table on April 30 in Chicago.
- Shadia Jalal, MD (EDT), and colleagues recently published the results of a clinical trial in the journal Frontiers in Oncology. The Big Ten Cancer Research Consortium has more details about the study and its findings.
- Cancer center director Kelvin Lee, MD (HHM), discusses precision medicine in this OncLive story.
- James Cleary, MD, was among the speakers for The Soul of Medicine in the Last Year of Life: Novel Solutions to Palliative Care Access Across Economic and Culture Divides Symposium.
New members
- Hyun Cheol Roh, PhD
Associate member, Tumor Microenvironment and Metastasis - Lata Balakrishnan, PhD
Full member, Experimental and Developmental Therapeutics - Reshma Bhowmick, PhD
Associate member, Experimental and Developmental Therapeutics - Laura M. Snell, PhD
Associate member, Hematopoiesis & Hematologic Malignancies